Cargando…
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
BACKGROUND: The pathophysiology of schizophrenia, a major psychiatric disorder, remains elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor (RXR) families, belonging to the ligand-activated nuclear receptor superfamily, in schizophrenia, was anal...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728824/ https://www.ncbi.nlm.nih.gov/pubmed/33279456 http://dx.doi.org/10.1016/j.ebiom.2020.103130 |